Corpus Intelligence IC Memo — COLUMBIA MEMORIAL HOSPITAL 2026-04-26 10:39 UTC
IC Memo — COLUMBIA MEMORIAL HOSPITAL
Investment Committee Memorandum | OR | 25 beds | Grade B | EBITDA uplift $12.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COLUMBIA MEMORIAL HOSPITAL

CCN 381320 | CLATSOP, OR | 25 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

COLUMBIA MEMORIAL HOSPITAL is a 25-bed suburban community hospital in CLATSOP, OR with $165.9M in net patient revenue and a 5.2% operating margin. The hospital serves a payer mix of 56.0% Medicare, 2.4% Medicaid, and 41.6% commercial.

Thesis: Turnaround. Our ML models identify $12.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.2% to 12.6% (+736bps).

Net Revenue HCRIS$165.9M
Current EBITDA COMPUTED$8.6M
Operating Margin COMPUTED5.2%
Occupancy HCRIS52.6%
Revenue / Bed COMPUTED$6.6M
Net-to-Gross HCRIS49.6%
Distress Probability ML42.3%

2. Market Context & Competitive Position

63
OR Hospitals
-8.1%
State Median Margin
34
Comparable Hospitals

OR has 63 Medicare-certified hospitals with a median operating margin of -8.1%. The target's margin of 5.2% places it above the state median. Among 34 size-comparable peers (12-50 beds), the median margin is -6.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 34 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COLUMBIA MEMORIAL HOSPITAL (Target)OR25$165.9M5.2%
GOOD SHEPHERD MEDICAL CENTEROR25$177.5M5.3%
SAMARITAN LEBANON COMM HOSPITAOR25$157.9M3.9%
PROVIDENCE NEWBERG MEDICAL CENOR40$151.5M10.0%
SAMARITAN PACIFIC COMM HOSPITAOR25$141.7M3.7%
GRANDE RONDE HOSPITALOR25$134.8M-4.1%
PROVIDENCE MILWAUKIE HOSPITALOR40$128.8M-9.6%
MID-COLUMBIA MEDICAL CENTEROR44$123.2M-20.0%
SILVERTON HOSPITALOR29$118.4M-16.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.5M+210bp18mo
Cost to Collect4.5%2.5%$3.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.0M+122bp9mo
Clean Claim Rate88.0%96.0%$106K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.5M
Cost to Collect
$3.3M
Denial Rate Reduction
$3.3M
A/R Days Reduction
$2.0M
Clean Claim Rate
$106K
Total EBITDA Uplift$12.2M
Current EBITDA$8.6M
+ RCM Uplift+$12.2M
Pro Forma EBITDA$20.8M
Current Margin5.2%
Pro Forma Margin12.6%
WC Released (1x)$6.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$13.3M$179.1M13.49x68.3%
Base (11x exit)10.0x11.0x$13.3M$201.3M15.16x72.2%
Bull Case9.0x11.0x$12.0M$245.9M20.58x83.1%
Bull (12x exit)9.0x12.0x$12.0M$271.8M22.74x86.8%
Bear Case11.0x10.0x$14.6M$113.7M7.78x50.7%
Bear (11x exit)11.0x11.0x$14.6M$129.8M8.89x54.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 56.0% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 34 hospitals with 12-50 beds
  • Same-state prioritization (n=35)
  • Comp margins: P25=-15.5% / P50=-6.2% / P75=3.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.